List of Excipients in API ertugliflozin and metformin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ertugliflozin and metformin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | SEGLUROMET | ertugliflozin and metformin hydrochloride | 0006-5369 | CARNAUBA WAX | 2030-10-21 |
| Merck Sharp & Dohme LLC | SEGLUROMET | ertugliflozin and metformin hydrochloride | 0006-5369 | CELLULOSE, MICROCRYSTALLINE | 2030-10-21 |
| Merck Sharp & Dohme LLC | SEGLUROMET | ertugliflozin and metformin hydrochloride | 0006-5369 | CROSPOVIDONE | 2030-10-21 |
| Merck Sharp & Dohme LLC | SEGLUROMET | ertugliflozin and metformin hydrochloride | 0006-5369 | FERRIC OXIDE RED | 2030-10-21 |
| Merck Sharp & Dohme LLC | SEGLUROMET | ertugliflozin and metformin hydrochloride | 0006-5369 | HYDROXYPROPYL CELLULOSE | 2030-10-21 |
| Merck Sharp & Dohme LLC | SEGLUROMET | ertugliflozin and metformin hydrochloride | 0006-5369 | HYPROMELLOSE | 2030-10-21 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ertugliflozin and metformin hydrochloride
Excipient focus: CARNAUBA WAX
ertugliflozin and metformin hydrochloride drug variants containing CARNAUBA WAX
ertugliflozin and metformin hydrochloride drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ertugliflozin and metformin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
ertugliflozin and metformin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
ertugliflozin and metformin hydrochloride drug variants containing CROSPOVIDONE
ertugliflozin and metformin hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ertugliflozin and metformin hydrochloride drug variants containing FERRIC OXIDE RED
ertugliflozin and metformin hydrochloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ertugliflozin and metformin hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
ertugliflozin and metformin hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ertugliflozin and metformin hydrochloride drug variants containing HYPROMELLOSE
ertugliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ertugliflozin and metformin hydrochloride drug variants containing MAGNESIUM STEARATE
ertugliflozin and metformin hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
ertugliflozin and metformin hydrochloride drug variants containing POVIDONE
ertugliflozin and metformin hydrochloride drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
ertugliflozin and metformin hydrochloride drug variants containing SODIUM LAURYL SULFATE
ertugliflozin and metformin hydrochloride drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ertugliflozin and metformin hydrochloride drug variants containing TITANIUM DIOXIDE
ertugliflozin and metformin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch